Cholesterol is an essential component of cell membranes and plays a role in numerous processes, particularly in the brain. Disruptions in its metabolism have been observed in many pathologies such as epilepsy and neurodegenerative diseases.
In the brain, cholesterol is transformed into 24-hydroxycholesterol to be exported through the blood-brain barrier. The enzyme responsible for this transformation is cholesterol 24-hydroxylase, also known as CYP46A1.
In a study published in the European Journal of Nuclear Medicine and Molecular Imaging, researchers from the BrainMAPS team of BioMaps (SHFJ) compare two radioligands specifically targeting CYP46A1 and used in positron emission tomography (PET). They show that one of them ([18F]CHL-2205) is sensitive enough to detect low variations in the expression of CYP46A1 in the brains of animals of different species, healthy or models of Alzheimer's disease.
Contact at the Frédéric-Joliot Institute for Life Sciences: